Perfect Medical Health Management Limited
HKEX:1830.HK
2.58 (HKD) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,393.339 | 1,389.261 | 1,349.971 | 1,089.768 | 1,240.95 | 1,197.031 | 906.275 | 756.975 | 879.122 | 728.655 | 470.236 | 443.026 | 381.16 | 308.976 |
| Cost of Revenue
| 701.185 | 726.662 | 660.044 | 536.332 | 525.928 | 354.336 | 301.715 | 263.819 | 282.83 | 243.266 | 141.408 | 8.764 | 0 | 0 |
| Gross Profit
| 692.154 | 662.599 | 689.927 | 553.436 | 715.022 | 842.695 | 604.56 | 493.156 | 596.292 | 485.389 | 328.828 | 434.262 | 381.16 | 308.976 |
| Gross Profit Ratio
| 0.497 | 0.477 | 0.511 | 0.508 | 0.576 | 0.704 | 0.667 | 0.651 | 0.678 | 0.666 | 0.699 | 0.98 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 23.141 | 15.263 | 12.342 | 60.87 | 70.999 | 89.413 | 75.224 | 81.041 | 91.886 | 75.139 | 40.443 | 41.786 | 40.105 | 29.875 |
| Selling & Marketing Expenses
| 159.596 | 150.846 | 182.633 | 153.277 | 136.794 | 169.111 | 87.955 | 76.439 | 113.698 | 73.81 | 82.496 | 78.134 | 61.901 | 56.42 |
| SG&A
| 316.553 | 293.788 | 304.662 | 250.191 | 259.732 | 263.204 | 188.997 | 186.48 | 219.184 | 154.697 | 138.542 | 119.92 | 102.006 | 86.295 |
| Other Expenses
| 347.283 | -0.482 | -1.473 | -0.373 | -1.499 | -1.463 | -81.082 | 1.998 | 0.317 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 316.553 | 293.788 | 306.135 | 250.564 | 261.231 | 444.181 | 353.885 | 381.855 | 442.977 | 315.443 | 222.205 | 314.812 | 293.34 | 243.513 |
| Operating Income
| 375.601 | 368.811 | 383.792 | 302.872 | 453.791 | 395.865 | 236.344 | 117.681 | 161.425 | 171.047 | 98.907 | 105.48 | 87.82 | 65.463 |
| Operating Income Ratio
| 0.27 | 0.265 | 0.284 | 0.278 | 0.366 | 0.331 | 0.261 | 0.155 | 0.184 | 0.235 | 0.21 | 0.238 | 0.23 | 0.212 |
| Total Other Income Expenses Net
| 8.122 | 22.645 | -5.639 | 55.288 | -3.213 | 8.188 | 18.47 | -0.572 | -0.711 | 5.696 | 10.888 | 4.326 | 2.467 | 0.238 |
| Income Before Tax
| 383.723 | 391.456 | 378.153 | 358.16 | 450.578 | 404.053 | 254.814 | 117.109 | 160.714 | 176.743 | 109.795 | 109.116 | 90.287 | 65.701 |
| Income Before Tax Ratio
| 0.275 | 0.282 | 0.28 | 0.329 | 0.363 | 0.338 | 0.281 | 0.155 | 0.183 | 0.243 | 0.233 | 0.246 | 0.237 | 0.213 |
| Income Tax Expense
| 73.324 | 75.818 | 72.908 | 73.526 | 90.421 | 85.02 | 60.627 | 25.753 | 30.697 | 41.831 | 26.771 | 31.101 | 21.615 | 15.441 |
| Net Income
| 315.8 | 315.638 | 305.245 | 284.634 | 360.157 | 319.033 | 194.187 | 91.356 | 130.017 | 134.912 | 83.024 | 78.015 | 68.672 | 50.26 |
| Net Income Ratio
| 0.227 | 0.227 | 0.226 | 0.261 | 0.29 | 0.267 | 0.214 | 0.121 | 0.148 | 0.185 | 0.177 | 0.176 | 0.18 | 0.163 |
| EPS
| 0.25 | 0.25 | 0.25 | 0.24 | 0.32 | 0.29 | 0.18 | 0.082 | 0.12 | 0.12 | 0.083 | 0.078 | 0.087 | 0.067 |
| EPS Diluted
| 0.25 | 0.25 | 0.25 | 0.24 | 0.32 | 0.29 | 0.18 | 0.082 | 0.12 | 0.12 | 0.083 | 0.078 | 0.087 | 0.067 |
| EBITDA
| 577.563 | 592.404 | 602.838 | 474.128 | 608.615 | 466.255 | 316.199 | 203.67 | 241.221 | 216.828 | 127.041 | 147.002 | 108.456 | 82.195 |
| EBITDA Ratio
| 0.415 | 0.426 | 0.447 | 0.435 | 0.49 | 0.39 | 0.349 | 0.269 | 0.274 | 0.298 | 0.27 | 0.332 | 0.285 | 0.266 |